I-MAB
(NASDAQ:IMAB)
$1.80
0[0.00%]
At close: Apr 19
$1.80
0[0.00%]
After Hours: 9:28AM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Feb
3
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About I-Mab
Sector
Health Care
Industry
Biotechnology
I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IMAB
ZURA

FAQ

Q

How do I buy I-MAB (IMAB) stock?

A

You can purchase shares of I-MAB (NASDAQ: IMAB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for I-MAB (IMAB) stock?

A

The latest price target for I-MAB (NASDAQ: IMAB) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 6.00 expecting IMAB to rise to within 12 months (a possible 233.33% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for I-MAB (IMAB)?

A

The stock price for I-MAB (NASDAQ: IMAB) is $1.8 last updated April 19, 2024 at 9:28 AM EDT.

Q

Does I-MAB (IMAB) pay a dividend?

A

There are no upcoming dividends for I-MAB.

Q

When is I-MAB (NASDAQ:IMAB) reporting earnings?

A

I-MAB’s FY earnings are confirmed for Friday, May 3, 2024.

Q

Is I-MAB (IMAB) going to split?

A

There is no upcoming split for I-MAB.

Q

What sector and industry does I-MAB (IMAB) operate in?

A

I-MAB is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch